Brand Name | Status | Last Update |
---|---|---|
aquabain antibacterial fresh and relax | OTC monograph not final | 2021-12-14 |
carisoprodol | ANDA | 2024-02-08 |
carisoprodol and aspirin | ANDA | 2010-12-10 |
mixed sanitizing towlettes | OTC monograph not final | 2017-12-20 |
prazolamine | unapproved drug other | 2011-08-01 |
relax sanitizing towlette | OTC monograph not final | 2018-01-29 |
soma | New Drug Application | 2023-05-15 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Low back pain | D017116 | HP_0003419 | M54.5 | — | — | 4 | — | — | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic pain | D059350 | HP_0012532 | — | — | — | — | — | 1 | 1 |
Anxiety | D001007 | EFO_0005230 | F41.1 | — | — | — | — | 1 | 1 |
Drug common name | Carisoprodol |
INN | carisoprodol |
Description | Carisoprodol is a carbamate ester that is the mono-N-isopropyl derivative of meprobamate (which is a significant metabolite). Carisoprodol interrupts neuronal communication within the reticular formation and spinal cord, resulting in sedation and alteration in pain perception. It is used as a muscle relaxant in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. It has a role as a muscle relaxant. |
Classification | Small molecule |
Drug class | Carbamate |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCCC(C)(COC(N)=O)COC(=O)NC(C)C |
PDB | — |
CAS-ID | 78-44-4 |
RxCUI | — |
ChEMBL ID | CHEMBL1233 |
ChEBI ID | 3419 |
PubChem CID | 2576 |
DrugBank | DB00395 |
UNII ID | 21925K482H (ChemIDplus, GSRS) |